GLG Topic: Biotech Industry
The Biotech Industry is the business sector encompassing the production and use of living organisms or active components to make or modify commercial products. This process is the predominant focus of organizations known as biotechnology companies.
Request a consultation
Leading Experts: Biotech Industry
 |
What is a GLG Leader? |
Peter Culpepper, CPA, MBAChief Financial Officer
Provectus Pharmaceuticals, Inc.
Peter Culpepper is the Chief Financial Officer at Provectus Pharmaceuticals. Mr. Culpepper has experience in medical device, biotech, healthcare OTC, specialty pharma and, therapeutic products. Previous to that, Mr. Culpepper served as the Chief Financial Officer at Felix Culpepper International, Inc....
Volunteer Professor of Law
University of Cincinnati - CC
James O'Reilly is Volunteer Professor of Law at University of Cincinnati, where he has counseled large and small drug, biotech, device and food firms since becoming a full time professor in 1998. Prof. O’Reilly’s 31 books and 137 articles have been widely cited, and as an FDA expert over many years...
B. Michael Silber, PHDChief of Drug Discovery R & D
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
Michael Silber, PhD, is Chief of Drug Discovery R & D and Adjunct Professor of Neurology and Biopharmaceutical Sciences, Institute for Neurodegenerative Diseases, at UCSF Medical School. He has over 25 years of expertise in all aspects of Pharma and Biotech R & D and API and biologics manufacturing,...
Jeff StierAssociate Director
American Council on Science and Health
Jeff Stier is an Associate Director at the American Council on Science and Health, a public health and consumer advocacy organization dedicated to promoting sound science in public health. In this position, he is responsible for government relations, policy, legal affairs and development. Mr. Stier...
Steven ColvilleCEO
SigmaSoft International
Steven Colville is the CEO at SigmaSoft International a provider of data management software for clinical trials. Mr Colville is also the COO of SigmaClinical, a CRO providing data management and statistical services to the pharmaceutical, medical device and biotech industries. Mr. Colville has over...
Study Groups: Biotech Industry(?)
GLG NewsSM
Analysis: Biotech Industry(?)
Allowing "generic" versions of biotech drugs to market without full safety testing would endanger consumers
While disappointing for patients and caregivers, Pfizer's loss of a late-stage treatment for melanoma casts an even darker shadow on the ability of pharmaceutical and biotech companies to successfully bring new treatments to market. Coupled with other recent Phase 3 failures, this latest outcome points...
1. PHRMA's R&D budget may have grown by a smaller percentage and positions have been cut due to mergers and acquisitions. 2. Biotech and non-PHRMA pharmaceutical company growth with increasing headcount , growing budgets and improved cost efficiencies may account for a portion of these...
The Internet, Biotech and Cleantech are the sectors that benefited the most from venture capitals (VC) investments in 1Q08, despite a drop in VC investments to $7.1 billion in 1Q08. The economic slowdown has caused VC's to all but close their wallets to IPOs and M&As, which is the two most common...
The USPTO’s proposed rule changes, struck down in this important Glaxo federal court decision, would have added significant burdens to pharmaceutical companies in developing their IP portfolios and ultimately their drug treatments. The proposed changes were seemingly motivated to make the...
Quick Facts about GLG
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms